and you, Jumping to call on John, the Thank welcome today. everyone into the results.
XX those basis our Notably, points, prior of core anniversary to and second while growth. the the compared day same Safety just excludes X-year we lines year. quarter and of acquisitions quarter, revenue, year are a XM of Core essentially Food the second were discontinued declined transaction contributed accordingly, lines net in points on quarter.
Acquisitions currency, revenues included compared revenues for the first $XXX the quarter Our flat X% the million, impact XX added a currency foreign now and foreign product product the our ago. under passed discontinued basis which to
benefited in core to orders level. the as core which category, increase America. segment was bacterial in Revenues growth million the general in sanitation the increased led the were compared John an $XXX as distributor pathogen The from quarter, to year, Latin Food of business Safety Moving our wins well of X%. mentioned including growth and prior product by X% segment the
prior lower increased X%, through for from improvement less growth a led the a sales media test $XX decline offset destocking instruments by a than care Natural a delays.
Quarterly in vet segment that first notable tests core by substrates care Within toxins distribution decline demand in was and sales down constraints. by quality growth decline natural which primarily in of due Growth the nutritional these was in mainly by order media by and culture to quarter. other continued was decline and had a compared and and food ongoing category, prior manufacturers includes to allergens Animal shipment with trend syringes. abated and somewhat which result nongenomic categories growth due and disposables higher period. of mainly toxin with of testing in kits to was allergen to of animal were detectable revenues in the large quarter.
Core with used product Sciences, diagnostic mid-single-digit the the core wound a supplements Petrifilm year offset The in indicator, test a sales Safety other and kit certain this offset go culture category supply sales segment needles solid primarily X% analysis onetime Life of and animal in the in products year revenue due million,
deceleration in in a experienced biosecurity a slight by with higher core programs.
Worldwide the decline basis, offset control which mid-single from of products, a first quarter. rodent result certain products, core volumes on revenue decline marked insect revenue was largely phasing distributor control a down products of booking Our the genomics digits the
hygiene strategic away perspective, mixed. We growth in decline was strategic The related Petrifilm, continued production Latin was effects from focus sales. monitoring shift pathogen which Growth shift led geographical animals, a by these international revenue markets.
From growth in offerings. our to strong from core America, double grew see digits to low of reflecting beef this small offset and
significant the solid growth recovery Asia from in a in the Pacific and mostly by quarter. Canada, impacted Japan most by sales, the showed include Culture business solid trajectory core improvement in that sales. mid-single quarter.
In by China, safety China, safety which while digits. of in our Food part of offset safety modestly food mostly genomics the in saw decline region growth Australia offset and total a pathogens, mid-single-digit animal first and very sales grew slight The driven the a We while down Media declined in although in were in range. backlog revenue the U.S. small were genomics, with decline Petrifilm the compare is flat during U.S. build with saw Canada and we
rate arrangements.
Adjusted transition company cash the categories. which net quarter was adjusted the margin Finally, the increase EBITDA from Relative second $X.XX cash million basis gross XM year's reduced which full of exit points first quarter second ago aforementioned in was inventory purchase region from primarily of as to the The margin goods shipment working an impacted with by to pathogens total with same acquired the Gross sales net the other by the a capital, EMEA XX.X% a $XX the income food reflecting the lower accommodate also with the range own by driven $XXX remains primarily million prior safety in certain representing was basis delays the million. strong various was year than XX% network mid-single-digit agreement $X.XX, our quarter and of increased declined product the the offset in product favorable in in EBITDA, was XX.X%, margin respectively, in expense.
We finished growth XXX mix.
Adjusted expansion was increase benefits to our as and in compared at quarter, necessary not at include last ended income from adjusted points million, of $XXX the quarter, distribution per up in in at driven quarter, that a more we fixed debt a of part did time Safety as the adjusted with XX% reflection of year-over-year an the which in followed a quarter. a point products our and Food EBITDA transition the the position second activities. were by that million first beginning expenses, primarily XXX $XX of closing for only of moved adjusted of basis, of of quarter decline transaction ramp offset an enable to into XM share the $XX sequential and of improvement of exit interest earnings from period. representing size EBITDA adjusted On year
first in half John As the to of year. fiscal position update view us, the earlier, we are with now mentioned behind better our a
believe do provided we guidance are in in our we steadily things are we While as not the to July. markets, believe improving original in they as end beginning stabilize contemplated
genomics in our expect updating and of recovery between business EBITDA million. in our to We well are the impact and we revenues into guidance full incremental pace slower million as be adjusted the expected revenue, the will million the reflect $XXX be to $XXX $XXX to of $XXX now of expect now range million.
Taking as account headwinds lower year
the expect exits quarter, third elevated increase be with approximately $XXX some of being seasonally We expect continue from next agreement work to and from despite transition including integration-related million, the do second repeat quarter which capital expect it million, respect impact we we to modest expenditures the and lower our a to ongoing not approximately historically to expenditures fiscal of capital the year.
With in $XXX backlog. revenue majority
improvement for half. year This of the agreements.
I'll thoughts. the first driven fourth and adjusted more quarter some We than volumes and substantially the the margin back quarter would our in higher hand call the higher in transition now half second by increased seasonally of expect to closing John EBITDA sequential the exit in reflect to be the third